Brief: CareRx Q4 revenue CAD 91.097 million
07/03/2024 12:04
Mar 7 (Reuters) - CareRx Q4 adjusted EBITDA CAD 7.505 million. * Q4 adjusted EBITDA margin 8.2% * Q4 net income CAD -3.7 million * Q4 EBITDA CAD 5.486 million * Q4 revenue CAD 91.097 million vs. IBES estimate CAD 93.3 million
Recent news on CareRx
See all newsCanada's CareRx Q1 revenue and adjusted EBITDA rise
Canada's CareRx quarterly revenue slightly beats estimates on beds serviced growth
Long-term care pharmacy CareRx Q3 revenue misses analyst expectations
Canada's CareRx Q2 revenue in-line with estimates
Brief: CareRx Reports Results For The Third Quarter Of 2024